Penny Heaton

Penny M. Heaton is an American physician who is the Global Therapeutics Lead for Vaccines at Johnson & Johnson. She previously worked at Novavax, Novartis and the Bill & Melinda Gates Foundation. She was included by Stat News on their definitive list of leaders in the life sciences in 2022.

Early life and education Heaton has said that she was inspired to work on vaccine development after hearing her father suffered from tuberculosis before she was born. She has credited her high school science teachers with teaching her the importance of blind controlled trials. She worked as a services officer for Epidemic Intelligence at the Centers for Disease Control and Prevention, studying food-borne viruses in infants born to HIV positive mothers. She went on to work in Kenya, where she investigated the roll-out of vaccines in impoverished populations in Kisumu. The vaccine was recommended by the World Health Organization for all infants around the world, and was predicted to save almost two million lives over the course of ten years.

Heaton was made Global Head of Vaccine Research Clusters at Novartis where she worked on maternal immunization, with a particular focus on Group B streptococcal infection. She worked on vaccines against Meningococcal meningitis, including Bexsero and Men.

After 3 years at Novartis, Heaton joined the Bill & Melinda Gates Foundation as Director of Vaccine Development She was recruited as global lead for vaccines at Johnson & Johnson in 2021.

Awards and honors 2018 University of Louisville School of Medicine Alumni of the Year 2022 Stat News Status List

Selected publications